← SynDRA

ZANDELISIB

SynDRA canonical compound SYN0040101 — structure-anchored drug synonym record

All known targets

• PIK3CD
• MTOR
• PIK3CA
• PIK3CB
• PIK3CG

Mechanisms of action (all sources)

• PIK3CD INHIBITOR
• PI3-kinase p110-delta subunit inhibitor
• MTOR inhibitor
• PIK3CA INHIBITOR
• PIK3CB INHIBITOR
• PIK3CG INHIBITOR
• PI3K inhibitor

Cross-references

• PubChem CID: 66571003
• ChEMBL: CHEMBL4650214
• DrugBank: DB18245
• KEGG: D12009
• PDB: A1L62
• Wikipedia: Zandelisib
• TTD: D8IQ0D

Synonyms

• ME-401
• PWT-143
• ACC-524
• PW-143
• PWT143
• UNII-8Z28M5SX0X
• 8Z28M5SX0X
• 4-yl)-1,3,5-triazin-2-amine
• [2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl}-6-(morpholin-
• 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-{2-methyl-1-
• Zandelisib [INN]
• Zandelisib [USAN]
• SCHEMBL12936730
• GTPL10627
• ME401
• WHO 11202
• ZINC148868634
• Example 51 [WO2012135160A1]
• HY-109198
• CS-0119144
• A35 [WO2012135160A1]
• 1,3,5-Triazin-2-amine, 4-(2-(difluoromethyl)-1H-benzimidazol-1-yl)-N-(1,1-dimethyl-2-(2-(1-methyl-4-piperidinyl)phenyl)ethyl)-6-(4-morpholinyl)-
• 4-(2-(Difluoromethyl)benzimidazol-1-yl)-N-(1,1-dimethyl-2-(2-(1-methyl-4-piperidyl)phenyl)ethyl)-6-morpholino-1,3,5-triazin-2-amine
• 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
• Me-401
• RefChem:195844
• PI3K-delta Inhibitor PWT143
• Zandelisib?
• ZANDELISIB [JAN]
• Zandelisib [USAN:INN]
• ZANDELISIB [WHO-DD]
• Zandelisib (JAN/USAN/INN)
• orb1308922
• SCHEMBL29366620
• SCHEMBL30089332
• SCHEMBL30165731
• C31H38F2N8O
• WPFUFWIHMYZXSF-UHFFFAOYSA-N
• A1L62